Zions Bancorporation’s Co-Diagnostics CODX Stock Holding History

Zions Bancorporation’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-333	Closed	-$97K	–	1008
2021 Q3	$97K	Hold	333	–	–	0.01%	377
2021 Q2	$83K	Hold	333	–	–	0.01%	370
2021 Q1	$95K	Hold	333	–	–	0.01%	346
2020 Q4	$93K	Hold	333	–	–	0.01%	324
2020 Q3	$136K	Sell	333 -334	-50%	-$172K	0.02%	265
2020 Q2	$387K	Sell	667 -166	-20%	-$75.8K	0.06%	130
2020 Q1	$191K	Buy	+833	New	+$144K	0.03%	186

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

ARC

Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Zions Bancorporation's CODX Position: Q4 2021 in Review

Zions Bancorporation sold out of Co-Diagnostics (CODX) in Q4 2021, closing a stake of 333 shares — an estimated $97K sold.

Zions Bancorporation first reported a position in CODX in Q1 2020 and held it in 7 quarters. The position peaked at $387K in Q2 2020. 77 funds tracked by Wall St. Rank hold CODX as of Q4 2021.

Zions Bancorporation reported no remaining Co-Diagnostics position as of Q4 2021 after selling out during the quarter.
Zions Bancorporation sold 333 Co-Diagnostics shares in Q4 2021, an estimated $97K.
Zions Bancorporation first reported a position in Co-Diagnostics in Q1 2020 and held it in 7 quarters.
Zions Bancorporation's Co-Diagnostics position peaked at $387K in Q2 2020.
77 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2021.

Based on Zions Bancorporation's 13F filing for Q4 2021, filed 11 Feb 2022.